American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 883 | 1,758 | 729 | 879 | 895 |
| Cost of Goods | 648 | 1,176 | 539 | 666 | 536 |
| Gross Profit | 235 | 582 | 190 | 213 | 359 |
| Operating Expenses | 1,055 | 742 | 1,000 | 1,062 | 976 |
| Operating Income | -172 | 16 | -271 | -183 | -81 |
| Interest Expense | 42 | 37 | 53 | 65 | 66 |
| Other Income | 0 | 0 | -1 | 0 | 3 |
| Pre-tax Income | -214 | -21 | -325 | -248 | -144 |
| Income Tax | 2 | 0 | 0 | -3 | 0 |
| Net Income Continuous | -216 | -21 | -325 | -245 | -144 |
| Net Income | $-216 | $-21 | $-325 | $-245 | $-144 |
| EPS Basic Total Ops | -0.01 | 0.00 | -0.01 | -0.01 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | 0.00 | -0.01 | -0.01 | 0.00 |
| EPS Diluted Total Ops | -0.01 | 0.00 | -0.01 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | 0.00 | -0.01 | -0.01 | 0.00 |
| EBITDA(a) | $-153 | $37 | $-214 | $-137 | $-35 |